78 related articles for article (PubMed ID: 18303603)
21. Will we be able to "cure" metastatic renal cell carcinoma like we cure testicular tumours?
Kirkali Z
Eur Urol; 2008 Oct; 54(4):712-4. PubMed ID: 18640767
[No Abstract] [Full Text] [Related]
22. Prognostic implications of polymorphisms and interleukin-2 therapy for renal cell carcinoma.
Gardner TA; Logan T
J Urol; 2009 Aug; 182(2):425-6. PubMed ID: 19524946
[No Abstract] [Full Text] [Related]
23. Recent investigations of histone deacetylase inhibitors in renal cell carcinoma.
Pili R
Clin Adv Hematol Oncol; 2009 Apr; 7(4):252-4. PubMed ID: 19521328
[No Abstract] [Full Text] [Related]
24. Clinical response of renal cell carcinoma to dexamethasone.
Schöffski P; Wolter P; Vandenborre K; Haustermans K
Cancer Invest; 2009 Jun; 27(5):529-32. PubMed ID: 19340657
[No Abstract] [Full Text] [Related]
25. Angiogenesis inhibition in non-clear cell renal cancer.
Stadler W
Clin Adv Hematol Oncol; 2008 Jul; 6(7):507-9. PubMed ID: 18654117
[No Abstract] [Full Text] [Related]
26. New therapies after failure of angiogenesis inhibitors.
Escudier B
Clin Adv Hematol Oncol; 2009 Aug; 7(8):512-4. PubMed ID: 19927977
[No Abstract] [Full Text] [Related]
27. Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany.
Gerullis H; Bergmann L; Maute L; Eimer C; Otto T
Cancer Chemother Pharmacol; 2009 May; 63(6):1097-102. PubMed ID: 18818922
[TBL] [Abstract][Full Text] [Related]
28. Open clinical uro-oncology trials in Canada.
Rodrigues G; Winquist E; Mackenzie MJ
Can J Urol; 2009 Aug; 16(4):4795-800. PubMed ID: 19671240
[No Abstract] [Full Text] [Related]
29. Could rigorous diagnosis and management of hypertension reduce cardiac events in patients with renal cell carcinoma treated with tyrosine kinase inhibitors?
Bamias A; Lainakis G; Manios E; Koroboki E; Karadimou A; Zakopoulos N; Dimopoulos MA
J Clin Oncol; 2009 May; 27(15):2567-9; author reply 2569-70. PubMed ID: 19332708
[No Abstract] [Full Text] [Related]
30. Prolonged response to temsirolimus in a pre-treated patient with metastatic renal cell carcinoma and poor performance status.
Jafri M; Douis H; Porfiri E
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):657-8. PubMed ID: 18644704
[No Abstract] [Full Text] [Related]
31. Editorial comment.
Oya M
J Urol; 2009 Dec; 182(6):2577. PubMed ID: 19836782
[No Abstract] [Full Text] [Related]
32. Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
Bellmunt J; Ribas A
Eur Urol; 2009 Jun; 55(6):1342-3. PubMed ID: 19201525
[No Abstract] [Full Text] [Related]
33. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.
Gupta K; Miller JD; Li JZ; Russell MW; Charbonneau C
Cancer Treat Rev; 2008 May; 34(3):193-205. PubMed ID: 18313224
[TBL] [Abstract][Full Text] [Related]
34. Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
Clark PE
Eur Urol; 2009 Jun; 55(6):1343-4. PubMed ID: 19201523
[No Abstract] [Full Text] [Related]
35. Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma.
Rini BI; Flaherty K
Urol Oncol; 2008; 26(5):543-9. PubMed ID: 18774471
[TBL] [Abstract][Full Text] [Related]
36. The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy.
Chowdhury S; Harper PG; Choueiri TK
Nat Clin Pract Oncol; 2008 Dec; 5(12):698-9. PubMed ID: 18852722
[No Abstract] [Full Text] [Related]
37. Re: Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results from DARENCA Study 2.
Laguna MP
J Urol; 2016 Mar; 195(3):608. PubMed ID: 26887702
[No Abstract] [Full Text] [Related]
38. Successful sorafenib treatment for metastatic renal cell carcinoma in a case with chronic renal failure.
Ruppin S; Protzel C; Klebingat KJ; Hakenberg OW
Eur Urol; 2009 Apr; 55(4):986-8; quiz 988. PubMed ID: 19004541
[TBL] [Abstract][Full Text] [Related]
39. New therapeutic developments in renal cell cancer.
Prenen H; Gil T; Awada A
Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971
[TBL] [Abstract][Full Text] [Related]
40. For: Radical nephrectomy in the setting of metastatic renal cell cancer: proceed judiciously.
Aron M; Gill IS
J Urol; 2009 Sep; 182(3):832-3. PubMed ID: 19643447
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
